Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Ivax

This article was originally published in The Rose Sheet

Executive Summary

Ivax: Personal care product revenues in 1994 were flat (down .6%) at $63 mil., the company reports in a recent 10-K filing with the Securities and Exchange Commission. The segment represents 5.6% of the company's total 1994 revenues, which were up 6.8% to $1.13 bil. Gross profit for personal care products dropped 8.5% in 1994 to $36.1 mil., contributing to a net gross profit decrease of 2.2% to 481.4 mil. During 1994, Ivax introduced Flori Roberts My Everything skin treatment line with AHAs ("The Rose Sheet" Aug. 22, 1994, p. 1) and Colores Para Tia color cosmetics for Hispanic women ("The Rose Sheet" June 27, 1994, p. 6). In January 1994, the firm acquired Posner Labs ("The Rose Sheet" Jan. 24, 1994, p. 1)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS001668

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel